Fig. 2From: Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund databaseThe cumulative probability of 5-ASA, steroid, IS and biological therapy in the whole observation periodBack to article page